A Randomized, double-blind, crossover, non-inferiority study comparing bronchodilator effects of single dose of 18 mcgg of Tiotropium Bromide and two doses of 12 mcg of Formoterol Fumarate each over 24 hours in subjects with moderate to severe asthma.

Trial Profile

A Randomized, double-blind, crossover, non-inferiority study comparing bronchodilator effects of single dose of 18 mcgg of Tiotropium Bromide and two doses of 12 mcg of Formoterol Fumarate each over 24 hours in subjects with moderate to severe asthma.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Formoterol; Tiotropium bromide
  • Indications Asthma
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 03 May 2013 Planned number of patients 30 added as reported by Clinical Trials Registry - India.
    • 22 Sep 2010 Results presented at the 20th Annual Congress of the European Respiratory Society
    • 01 Jul 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top